Shorted
Percheron Therapeutics logo
PER
Pharmaceuticals, Biotechnology & Life Sciences

Percheron Therapeutics

Short interest
0.02%
−0.14 pp 30d
as of 21 Feb 2025
Reported shorts
237.1K
Shares on issue
1.087B

Percheron Therapeutics (PER) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Neutral
19h ago

Why Is Percheron Therapeutics (ASX:PER) Seeking Quotation for a Major New Share Issue?

Highlights Percheron Therapeutics (ASX:PER) has applied for ASX quotation of a very large block of new fully paid ordinary shares, issued at a very low price The issue follows a previously lodged capital raising notice and supplies fresh funding for its operations The scale is large relative to the companys very small market capitalisation, so dilution is the key consideration Percheron Therapeutics (ASX:PER) has applied to the ASX for quotation of a very large tranche of new fully paid ordina...

Continue reading
Kalkine
Neutral
6d ago

Percheron Therapeutics Grants 75 Million Performance Restricted Stock Units to Dr. Baker

On 8 October 2026, Percheron Therapeutics Limited (ASX:PER) issued 75,000,000 Performance Restricted Stock Units (PRSUs) as part of the incentive component of Dr. Baker's remuneration package, in line with his employment contract announced on 10 August 2026. Key Points 75,000,000 Performance Restricted Stock Units issued on 8 October 2026 as a new unquoted class of securities Issued as an incentive element of Dr. Baker's remuneration under his employment contract revealed on 10 August 2026 No...

Continue reading
Kalkine
Neutral
1 Sept

Percheron Therapeutics (ASX:PER) Leads Small-Cap Market Focus

Highlights Percheron Therapeutics advances funding for a new acute myeloid leukaemia clinical trial. Nova Minerals outlines its US antimony strategy as critical-minerals activity intensifies. Kingfisher Mining reports high-grade silver-lead-zinc mineralisation near Broken Hill. The Australian share market is facing another closely watched session for smaller listed companies, with the S&P/ASX Small Ordinaries under pressure as healthcare, mining and critical-minerals developments drive com...

Continue reading
Kalkine
Neutral
14 Aug

Percheron Therapeutics (ASX:PER) Share Quotation Update Sparks Fresh Market Interest

Highlights Percheron Therapeutics has confirmed the quotation of newly issued ordinary shares on the ASX. The update reflects another step in the company's ongoing capital management activities. The latest filing strengthens transparency around the company's listed share capital. Australia's stock market continues to witness listed companies strengthening transparency through regular regulatory disclosures. Percheron Therapeutics (ASX:PER), an Australian biotechnology company developing therap...

Continue reading